Literature DB >> 26299661

The Immune System in Cancer Prevention, Development and Therapy.

Serge M Candeias1, Udo S Gaipl.   

Abstract

The immune system plays a pivotal role in the maintenance of the integrity of an organism. Besides the protection against pathogens, it is strongly involved in cancer prevention, development and defense. This review focuses on how the immune system protects against infections and trauma and on its role in cancer development and disease. Focus is set on the interactions of the innate and adaptive immune system and tumors. The role of IFN-γ as a pleiotropic cytokine that plays a very important role at the interface of innate and adaptive immune systems in tumor development and induction of anti-tumor immune responses is outlined. Further, immune cells as prognostic and predictive markers of cancer will be discussed. Data are provided that even the brain as immune privileged organ is subjected to immune surveillance and consequently also brain tumors. Immune therapeutic approaches for glioblastoma multiforme, the most frequent and malignant brain tumor, based on vaccination with dendritic cells are outlined and application of hyperthermia in form of magnetic nanoparticles is discussed. We conclude that the immune system and developing tumors are intimately intertwined. Anti-tumor immune responses can be prominently boosted by multimodal therapies aiming on the one hand to induce immunogenic tumor cell death forms and on the other hand to actively counteract the immune suppressive microenvironment based on the tumor itself.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26299661     DOI: 10.2174/1871520615666150824153523

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  33 in total

1.  Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.

Authors:  Amit Benbenishty; Niva Segev-Amzaleg; Lee Shaashua; Rivka Melamed; Shamgar Ben-Eliyahu; Pablo Blinder
Journal:  Brain Behav Immun       Date:  2017-02-20       Impact factor: 7.217

Review 2.  Trial watch: dendritic cell vaccination for cancer immunotherapy.

Authors:  Jenny Sprooten; Jolien Ceusters; An Coosemans; Patrizia Agostinis; Steven De Vleeschouwer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2019-07-18       Impact factor: 8.110

3.  Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells.

Authors:  Jonathan M Eby; Angela R Smith; Timothy P Riley; Cormac Cosgrove; Christian M Ankney; Steven W Henning; Chrystal M Paulos; Elizabeth Garrett-Mayer; Rosalie M Luiten; Michael I Nishimura; Brian M Baker; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2018-08-13       Impact factor: 4.693

4.  Editorial: Wound Recognition across the Tree of Life.

Authors:  Martin Heil; Walter G Land; Mahmut Tör
Journal:  Front Plant Sci       Date:  2016-09-01       Impact factor: 5.753

Review 5.  T cell senescence and CAR-T cell exhaustion in hematological malignancies.

Authors:  Dimitri Kasakovski; Ling Xu; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2018-07-04       Impact factor: 17.388

6.  Loss of TRP53 (p53) accelerates tumorigenesis and changes the tumor spectrum of SJL/J mice.

Authors:  Jane A Branca; Benjamin E Low; Ruth L Saxl; Jennifer K Sargent; Rosalinda A Doty; Michael V Wiles; Beth L Dumont; Muneer G Hasham
Journal:  Genes Cancer       Date:  2020

7.  BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways.

Authors:  Tham H Hoang; Yue Zhao; Yiu Lam; Stephanie Piekos; Yueh-Chiang Han; Cameron Reilly; Pujan Joshi; Seung-Hyun Hong; Chang Ohk Sung; Charles Giardina; Dong-Guk Shin
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

Review 8.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells.

Authors:  Stefania Parlato; Adele De Ninno; Rosa Molfetta; Elena Toschi; Debora Salerno; Arianna Mencattini; Giulia Romagnoli; Alessandra Fragale; Lorenzo Roccazzello; Maria Buoncervello; Irene Canini; Enrico Bentivegna; Mario Falchi; Francesca Romana Bertani; Annamaria Gerardino; Eugenio Martinelli; Corrado Natale; Rossella Paolini; Luca Businaro; Lucia Gabriele
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

10.  Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases.

Authors:  Josefine Nordvig; Theis Aagaard; Gedske Daugaard; Peter Brown; Henrik Sengeløv; Jens Lundgren; Marie Helleberg
Journal:  Open Forum Infect Dis       Date:  2018-10-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.